The development and spread of antibiotic resistance among bacteria affecting human health are most challenging problems of the modern world. The genetic determinants responsible for conferring resistance are often carried in self-transmissible mobile elements such as conjugative plasmids, gene cassettes in integrons and transposons, which are transferred between bacterial species, resulting in transmission of resistance to other species[@ref1].

The development of resistance to a specific antimicrobial compound is influenced by several environmental factors and it has been reported that the organisms isolated from environment with high faecal contamination can easily acquire resistance to the common antimicrobial drugs[@ref2]. In addition, the non-therapeutic use of antimicrobials in animal husbandry, aquaculture, agriculture, poultry and piggery has increased the incidence of multidrug resistance forms in the environment[@ref3][@ref4]. The presence of antibiotic resistance in Gram-negative bacteria has been well documented including their occurrence in aquaculture[@ref5] and livestock[@ref6]. Among the Gram-negative bacteria, the prevalence of antimicrobial resistance has been reported to be high in *Escherichia coli*[@ref7], *Salmonella* spp.[@ref8], *Vibrio* spp.[@ref9], *Pseudomonas* spp.[@ref10], *Citrobacter* spp.[@ref11] and *Proteus* spp.[@ref12]. It is important to understand and monitor the antibiotic resistance patterns of human pathogenic bacteria persisting in the environment. Hence, the main objective of this study was to investigate the phenotypic and genotypic profile of antimicrobial resistance in Gram-negative bacteria isolated from environmental samples.

Material & Methods {#sec1-2}
==================

A total of 250 samples from different sources, *viz*. 99 from fish and fishery products comprising 61 of fish/shellfish and 38 of oyster/clam/molluscs; 81 from livestock wastes comprising poultry (23), piggery (14) and cattle wastes (44) samples and 70 from aquaculture systems comprising fish farm water (40) and pond sediment (30), in and around Mangaluru, India, were aseptically collected fortnightly during the study period (2011-2014). The samples were subjected to isolation of associated bacteria by culture-based conventional methods[@ref13]. Typical colonies from the selective plates were sub-cultured onto Luria Bertani (L-B) agar (HiMedia Laboratories Pvt. Ltd., Mumbai) and identified using standard biochemical tests, *viz*. Gram staining, motility, cytochrome oxidase, catalase, oxidation fermentation test, urease and triple sugar iron agar[@ref14][@ref15]. *E. coli*, *Salmonella* spp. and *Vibrio* spp. were further confirmed by single-step PCR using species-specific primers ([Table I](#T1){ref-type="table"})[@ref16][@ref17][@ref18]. Identified isolates were preserved in 30 per cent glycerol L-B broth and stored at −80°C for further studies.

###### 

Primers used for the confirmation of suspected *Escherichia coli*, *Salmonella enterica* and *Vibrio* spp. isolates

  Isolate                   Gene                     Sequence 5'- 3'              Size (bp)   Tm (°C)    Reference
  ------------------------- ------------------------ ---------------------------- ----------- ---------- -----------
  *Escherichia coli*        *uidA*                   AAAACGGCAAGAAAAAGCAG         146         60         [@ref16]
  ACGCGTGGTTACAGTCTTGCG                                                                                  
  *Salmonella*              *invA*                   GTGAAATTATCGCCACGTTCGGGCAA   284         64         [@ref17]
  TCATCGCACCGTCAAAGGAACC                                                                                 
  *hns*                     TACCAAAGCTAAACGCGCAGCT   156                          60          [@ref18]   
  TGATCAGGAAATCTTCCAGTTGC                                                                                
  *Vibrio*                  16S rRNA                 GTAAATTATCGCCACGTTCGG        321         55         [@ref16]
  AACGGCAAGAAAAAGCAGTG                                                                                   

Tm, melting/annealing temperature of primers

*Antibiotic susceptibility test:* Antibiotic susceptibility tests were performed for all the isolates using the disc diffusion method described by Bauer *et al*[@ref19] as per the Clinical and Laboratory Standards Institute guidelines[@ref20]. Twelve common antibiotics (in μg) namely nalidixic acid (30), tetracycline (30), co-trimoxazole (25), ciprofloxacin (5), chloramphenicol (30), ampicillin (10), gentamicin (10), nitrofurantoin (300), imipenem (10), meropenem (10mc), cefotaxime (30) and piperacillin-tazobactam (100/10) (HiMedia) were used for antibiotic profiling. ATCC 25922 *E. coli* culture was used as a standard quality control strain for AST for *Enterobacteriaceae* groups.

*Detection of antibiotic resistance determinants by PCR:* The isolates showing resistance to particular antibiotics were selected and screened for the presence of antibiotic resistance determinants by PCR using the primers listed in [Table II](#T2){ref-type="table"}[@ref21][@ref22][@ref23][@ref24]. Genomic DNA was extracted from the bacterial culture by cetyl-trimethyl ammonium bromide method[@ref25]. Using genomic DNA as a template, PCR was carried out in 30 μl reaction mixture containing 10× buffer (100 mM Tris-HCl, *p* H 8.3, 20 mM MgCl~2~, 500 mM KCl, 0.1% gelatin), 200 mM of dNTPs (dATP, dTTP, dGTP and dCTP), 10 pmol each of forward and reverse primers and 1.0 unit of *Taq* DNA polymerase enzyme (HiMedia) in a MJ-Research Thermo Cycler (PTC-200, Bio-Rad, USA). The PCR conditions included initial denaturation at 94°C for 5 min, followed by 35 cycles with each cycle consisting of denaturation at 94°C for 60 sec, annealing for 60 sec at an optimized temperature depending on the primer set used and extension at 72°C for 30 sec. The final extension was set at 72°C for 10 min.

###### 

Primers used for detection of different antibiotic resistance genes

  Antimicrobials            Resistance genes            Forward and reverse primer 5'- 3'   Size (bp)   Present in samples   Reference
  ------------------------- --------------------------- ----------------------------------- ----------- -------------------- -----------
  Tetracycline              *tetA*                      TTGGCATTCTGCATTCACTC                494         Yes                  [@ref21]
  GTATAGCTTGCCGGAAGTCG                                                                                                       
  *tetB*                    CAGTGCTGTTGTTGTCATTAA       571                                 Yes                              
  GCTTGGAATACTGAGTGTTAA                                                                                                      
  *tetC*                    CTTGAGAGCCTTCAACCCAG        418                                 Yes                              
  ATGGTCGTCATCTACCTGCC                                                                                                       
  *tetD*                    GCAAACCATTACGGCATTCT        546                                 Yes                              
  GATAAGCTGCGCGGTAAAAA                                                                                                       
  *tetE*                    TATTAACGGGCTGGCATTTC        544                                 Yes                              
  AGCTGTCAGGTGGGTCAAAC                                                                                                       
  *tetG*                    GCTCGGTGGTATCTCTGCTC        550                                 Yes                              
  CAAAGCCCCTTGCTTGTTAC                                                                                                       
  *tetL*                    CATTTGGTCTTATTGGATCG        488                                 No          [@ref22]             
  ATTACACTTCCGATTTCGG                                                                                                        
  *tetM*                    GTTAAATAGTGTTCTTGGAG        657                                 Yes                              
  CTAAGATATGGCTCTAACAA                                                                                                       
  *tetS*                    TGGAACGCCAGAGAGGTATT        660                                 Yes                              
  ACATAGACAAGCCGTTGACC                                                                                                       
  Sulphonamides             *sul I*                     TTTCCTGACCCTGCGCTCTAT               425         Yes                  [@ref21]
  GTGCGGACGTAGTCAGCGCCA                                                                                                      
  *sul II*                  CCTGTTTCGTCCGACACAGA        435                                 Yes                              
  GAAGCGCAGCCGCAATTCAT                                                                                                       
  *sul III*                 ATGAGCAAGATTTTTGGAATCGTAA   792                                 Yes                              
  CTAACCTAGGGCTTTGGATATTT                                                                                                    
  Chloramphenicol           *cat1*                      AACCAGACCGTTCAGCTGGAT               549         Yes                  
  CCTGCCACTCATCGCAGTAC                                                                                                       
  *cat2*                    AACGGCATGATGAACCTGAA        547                                 Yes                              
  ATCCCAATGGCATCGTAAAG                                                                                                       
  *cat3*                    ATCGGCATCGGTTACCATGT        531                                 No                               
  ATCCCCTTCTTGCTGATATT                                                                                                       
  *cmlA*                    GGCCTCGCTCTTACGTCATC        662                                 Yes                              
  GCGACACCAATACCCACTAGC                                                                                                      
  *cmlB*                    ACTCGGCATGGACATGTACT        840                                 No                               
  ACGGACTGCGGAATCCATAG                                                                                                       
  *floR*                    ATGACCACCACACGCCCCG         1,213                               No                               
  AGACGACTGGCGACTTCTCG                                                                                                       
  Quinolones                *qnrA*                      ATTTCTCACGCCAGGATTTG                516         Yes                  [@ref23]
  GATCGGCAAAGGTTAGGTCA                                                                                                       
  *qnrB*                    GATCGTGAAAGCCAGAAAGG        469                                 Yes                              
  ACGATGCCTGGTAGTTGTCC                                                                                                       
  *qnrS*                    ACGACATTCGTCAACTGCAA        417                                 Yes                              
  TAAATTGGCACCCTGTAGGC                                                                                                       
  Ampicillin                *bla*~TEM~                  CTCACCCAGAAACGCTGGTG                569         Yes                  [@ref24]
  ATCCGCCTCCATCCAGTCTA                                                                                                       
  Cefotaxime                *bla*~CTX-M~                ACGTTAAACACCGCCATTCC                356         Yes                  
  TCGGTGACGATTTTAGCCGC                                                                                                       

*Sequencing of antibiotic-resistant determinants:* The amplified PCR products (antibiotic-resistant determinants) were purified using PCR Purification Kit (Qiagen, Hilden, Germany) according to the manufacturer\'s protocol and were outsourced for capillary sequencing. The obtained sequences were analyzed by BLAST (*<http://blast.ncbi.nlm.nih.gov>*) and antibiotic resistance genes database for their homology with the database sequences and the confirmed sequences were submitted to the GenBank.

Results {#sec1-3}
=======

Five hundred and nineteen bacterial strains were isolated and identified to the genus level by conventional methods using a battery of biochemical tests. The details of the isolates identified from the different sources are given in [Table III](#T3){ref-type="table"}. Molecular confirmation of *E. coli*, *Vibrio* spp. and *Salmonella* spp. was done by PCR using primers namely *uidA* for *E. coli*, *invA* and *hns* for *Salmonella* and 16S rRNA for *Vibrio* ([Fig. 1](#F1){ref-type="fig"}).

###### 

Total number of Gram-negative bacterial strains isolated from different non-human sources

  Source                                                               Number of samples   *Escherichia coli*   *Vibrio* spp.   *Salmonella* spp.   *Pseudomonas* spp.   *Citrobacter* spp.   *Proteus* spp.   Total
  -------------------------------------------------------------------- ------------------- -------------------- --------------- ------------------- -------------------- -------------------- ---------------- -------
  Fish and fishery products (fish/shrimps and clams/oysters/mussels)   99                  45                   169             8                   18                   6                    13               259
  Livestock wastes (poultry, piggery and cattle farm)                  81                  61                   7               6                   17                   10                   18               119
  Environmental samples (farm water and pond sediment)                 70                  10                   82              \-                  21                   10                   18               141
  Total                                                                250                 116                  258             14                  56                   26                   49               519

![Gel-electrophoresis of PCR amplified products of *Escherichia coli* and *Salmonella* isolates. Lane1: 100 bp DNA ladder; lane 2: *uidA* gene-positive control (*E. coli*); lane 3: *uidA* gene-negative control (*E. coli*); lanes 4 & 5: *uidA* gene-positive *E. coli* isolates; lane 6: positive control for *invA* gene (*Salmonella*); lane 7: negative control for *invA*; lanes 8 & 9: *invA* gene-positive *Salmonella* isolates; lane 10: positive control for *hns* gene (*Salmonella*); lane 11: negative control for *hns* gene; lanes 12-13: *hns* gene-positive *Salmonella* spp. isolates.](IJMR-149-232-g001){#F1}

*Antimicrobial susceptibility test:* Among the 519 isolates tested for antimicrobial susceptibility, only 31.6 per cent (164 isolates) showed susceptibility to all the antibiotics tested. While 68.4 per cent (355 isolates) were resistant to at least one of the antibiotics, 33.7 per cent (175 isolates) displayed multidrug resistance (resistance to more than one antibiotic). As shown in [Fig. 2](#F2){ref-type="fig"}, maximum resistance was observed for ampicillin (225 isolates, 43.4%) followed by nitrofurantoin (108 isolates, 20.8%), nalidixic acid (71 isolates, 13.7%), cefotaxime (62 isolates, 11.9%), tetracycline (58 isolates, 11.2%), co-trimoxazole (38 isolates, 7.3%), ciprofloxacin (30 isolates, 5.8%), gentamicin and piperacillin/tazobactam (28 isolates, 5.4%), imipenem (18 isolates, 3.5%), meropenem (16 isolates, 3.1%) and chloramphenicol (15 isolates, 2.9%).

![Antibiotic resistance pattern of all isolates against 12 different antibiotics used in the study. NA, nalidixic acid; TE, tetracycline; COT, co-trimoxazole; CIP, ciprofloxacin; C, chloramphenicol; AMP, ampicillin; GEN, gentamicin; NIT, nitrofurantoin; MRP, meropenem; CTX, cefotaxime; PIT, piperacillin/tazobactum.](IJMR-149-232-g002){#F2}

The drug resistance patterns of the isolates according to the source of collection are presented in [Fig. 3](#F3){ref-type="fig"}. Among isolates obtained from fishery products and environment samples, 47.5 per cent showed resistance to ampicillin and 18 per cent to nitrofurantoin, suggesting maximum resistance to these two antibiotics. Among isolates from livestock wastes, maximum resistance was observed for nitrofurantoin (33.6% of the isolates) followed by ampicillin (28.6% of the isolates) and tetracycline (22.7% of the isolates).

![Source-wise representation of antibiotic resistance pattern of the isolates to 12 antibiotics. Abbreviations are as given in [Fig. 2](#F2){ref-type="fig"}.](IJMR-149-232-g003){#F3}

*Detection of antibiotic resistance genes:* The antibiotic-resistant determinants associated with resistance were detected by PCR. Of the 58 isolates showing resistance to tetracycline, 45 (77.6%) harboured one or more than one tetracycline-resistant genes (*tetA, tetB, tetC, tetD, tetE, tetG, tetM* and *tetS*). Remaining 13 isolates did not carry any of the *tet* genes tested even though these were phenotypically resistant. Among 38 isolates resistant to co-trimoxazole, 12 (31.6%) harboured at least one of the *sul* genes (*sul1, sul2, sul3*) and the 26 isolates did not harbour any of the tested genes ([Fig. 4](#F4){ref-type="fig"}). Two hundred and twenty five ampicillin-resistant isolates were tested for the presence of *bla*~TEM~, the gene responsible for the resistance. However, only eight isolates (3.6%) showed the presence of this gene. Of the 62 cefotaxime-resistant isolates, only five (8%) had the *bla*~CTX-M~ gene conferring the resistance trait. Among the 15 isolates resistant to chloramphenicol, five (33.3%) carried one of the resistance genes (*cat1, cat2* and *cmlA*), but none of these showed the presence of *cat3, cmlB* and *floR* ([Fig. 5](#F5){ref-type="fig"}). Of the 71 nalidixic acid-resistant isolates, nine (12.7%) carried either *qnrA, qnrB or qnrS*.

![Detection of PCR amplified products of antibiotic resistance genes. Lane 1: 100 bp DNA ladder; lane 2: *tetA* (492 bp); lane 4: *tetB* (571 bp); lane 6: *tetE* (544 bp); lane 8: *sul1* (425 bp); lane 10: *sul2* (435 bp); lane 12: *sul3* (792 bp); lane 14: 500 bp DNA ladder and lanes 3, 5, 7, 9, 11, 13: negative controls.](IJMR-149-232-g004){#F4}

![Gel-electrophoresis of PCR amplified products of chloramphenicol-resistant isolates. Lane 1: 100 bp DNA ladder; lane 2: *cat1* gene-positive control; lane 3: *cat1* gene-negative control; lanes 4-5: *cat1* gene-positive isolates; lane 6: positive control for *cat2* gene; lane 7: negative control for *cat2* gene; lanes 8-9: *cat2* gene-positive isolates; lane 10: positive control for *cmlA* gene; lane 11: negative control for *cmlA* gene; lane 12-13: *cmlA* gene-positive isolates.](IJMR-149-232-g005){#F5}

Further, sequencing of the PCR products of antibiotic resistance genes from representative isolates revealed 98 per cent identity with the existing antibiotic resistance gene sequences in the database. The GenBank accession numbers of these sequences are given in [Table IV](#T4){ref-type="table"}.

###### 

List of antibiotic resistant gene sequences submitted to GenBank with accession number

  Title                                                                                                      Accession number
  ---------------------------------------------------------------------------------------------------------- ------------------
  *Escherichia coli* isolate T1 tetracycline resistance protein class A (*tetA*) gene, partial cds. (EC12)   KF240812.1
  *E. coli* strain T2 tetracycline resistance protein class B (*tetB*) gene, partial cds. (EC23)             KF240811.1
  *Salmonella* sp. T1a tetracycline resistance proteins class A (*tetA*) gene, partial cds. (S131)           KF240813.1
  *Salmonella* sp. S1a sulphonamide resistance protein (*sul1*) gene, partial cds. (S131)                    KF240817.1
  *E. coli* strain S2 sulphonamide resistance protein (*sul2*) gene, partial cds. (EC11)                     KF240815.1
  *E. coli* strain S3 sulphonamide resistance protein (*sul3*) gene, partial cds. (EC10)                     KF240814.1
  *E. coli* strain S1 sulphonamide resistance protein (*sul1*) gene, partial cds. (EC10)                     KF240816.1

Discussion {#sec1-4}
==========

The results of antibiotic susceptibility test revealed that the number of isolates showing resistance to one or more antibiotics was on the rise, suggesting the high occurrence of antibiotic resistance in animal, wastewater, soil and other natural environments. Regardless of their source of isolation, resistance to three antibiotics, namely ampicillin, nitrofurantoin and tetracycline, was most frequently observed. Although ampicillin resistance was highest among all the antibiotics used.

It has been shown that isolates from fish and shrimp farms have widespread resistance to nitrofurantoin[@ref26]. In this study, approximately 20 per cent of the isolates showed resistance to nitrofurantoin. Similarly, 18 per cent of the isolates obtained from fish farms and related products showed resistance to this antibiotic, and the results were in agreement with that of an earlier study[@ref27]. The resistance to nitrofurantoin could be either due to the inhibition of nitrofurantoin reductase or due to the nucleotide changes (mutation) in *nfs*A and *nfs*B encoding oxygen-insensitive nitro reductase. Nitrofurantoin and its metabolites have zero tolerance in fishery products, and yet the high occurrence of resistance to nitrofurantoin observed in the study indicating the use of this antibiotic in aquaculture and other environments.

Resistance to tetracycline has been reported frequently from environmental samples[@ref28]. In the present study, 11.2 per cent of the isolates exhibited phenotypic resistance to tetracycline, which was consistent with earlier studies that reported tetracycline resistance in 15-56 per cent of the isolates[@ref28]. Resistance to tetracycline is more frequently observed in poultry isolates because it is widely used as growth promoters in poultry production[@ref29]. More than 60 per cent of poultry isolates showed resistance to tetracycline in this study.

Skockova *et al*[@ref30] had earlier reported that *tetA* and *tetB* were the most common genes responsible for resistance to tetracycline. In our study, 77 per cent of the phenotypically resistant isolates showed the presence of one or more *tet* genes. Although the remaining 23 per cent did not carry any of the *tet* genes tested in the study despite being phenotypically resistant, the resistance in such isolates could be due to other mechanisms such as enzymatic inactivation or target modification[@ref31].

In this study, 7.3 per cent of the total isolates showed moderate resistance to co-trimoxazole. The sulphonamide resistance genes (*sul1, sul2* and *sul3*) are known to be associated with class 1 integrons responsible for capturing and excision of genes during site-specific recombination events[@ref32], which further facilitates the emergence of multidrug resistance among bacterial pathogens. Similar to the pattern seen for other antibiotics, the phenotypic and genotypic association was inconsistent for co-trimoxazole with only 31.6 per cent of the phenotypically confirmed isolates showing the presence of one of the three *sul* genes. The absence of *sul* in the remaining isolates suggests the possibility of some new genes or resistance mechanism to confer resistance to co-trimoxazole.

The antibiotic resistance pattern obtained for chloramphenicol in this study was low profile *i.e.*,2.9 per cent. The results of genotypic characterization showed inconsistency with 20 per cent carrying both type 1 and type 2 *cat* genes and 13.3 per cent harbouring *cmlA*. However, none of the isolates were positive for type 3 *cat*, *cmlB* and *floR*. The absence of resistance genes was observed in 33.3 per cent of the phenotypically resistant isolates, suggesting the possibility of other mechanism(s) such as overexpression of efflux pumps, mutations or modifications in the target sites or decreased outer membrane permeability contributing to chloramphenicol resistance[@ref33][@ref34].

The resistance to β-lactam group of antibiotics such as ampicillin, cefotaxime, imipenem, meropenem and piperacillin/tazobactam was also analyzed in this study. Except for ampicillin, which showed maximum resistance, the percentage of resistance was relatively less with 3.5 and 3.1 per cent of isolates showing resistance to imipenem and meropenem, respectively. In our study, 20 per cent of the isolates showed resistance to nalidixic acid and five per cent towards ciprofloxacin. The usual cause of resistance to quinolones is due to point mutation/mutations in the quinolone resistance determining regions (QRDR) or due to presence of active efflux or outer membrane permeability. In addition, the plasmid-mediated quinolone resistance (PMQR) has also been reported. In the present study, nalidixic acid- and ciprofloxacin-resistant isolates carried *qnrA, qnrB* and *qnrS* indicating that quinolone resistance was acquired through plasmid-mediated determinant. Although point mutations in the QRDR are the main reason for resistance to quinolone/fluoroquinolones, the occurrence of PMQR genes cannot be neglected since these play a major role in the transmission of resistance among bacterial isolates[@ref35]. The bacterial isolates showed similar pattern of resistance to cell wall synthesis inhibitors such as meropenem and imipenem. Although the susceptibility of the majority of the isolates to carbapenems was encouraging, the small percentage of resistance observed should be viewed seriously.

In conclusion, the results of this study on the pattern of resistance to antimicrobials in environmental samples highlighted the importance of continuous vigilance on the distribution of multidrug-resistant human pathogens in the environment. High rate of multidrug resistance among bacterial isolates from environmental samples suggested the indiscriminate use of antimicrobials in various sectors of animal husbandry. Judicious use of antibiotics, use of alternative bio-control approaches or development of pathogen-specific antimicrobial agents could help in combating antimicrobial resistance.
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